Dinesh Khanna, MD, MSc, is one of the world’s leading experts in systemic sclerosis and autoimmune disease. He serves as Professor of Rheumatology and Director of the Michigan Medicine Scleroderma Program at the University of Michigan.
Dr. Khanna has led numerous landmark clinical trials and helped develop the Combined Response Index in Systemic Sclerosis (CRISS), an outcome measure recognized by the American College of Rheumatology and under FDA qualification. He has authored more than 300 peer-reviewed publications and advises multiple global pharmaceutical companies on autoimmune and fibrotic disease programs.
Dr. Khanna maintains extensive collaborations with the biopharmaceutical industry, serving as a principal investigator and scientific advisor on multiple clinical development programs with leading global pharmaceutical companies. Through these roles, he contributes to the advancement of innovative therapies and the integration of translational insights into late-stage clinical development.